Showing results (1-10 of 900) with videos related to
Sort By:
Pageof 90
Current Opinion in Critical Care|June 16, 2025
Veno-arterial extracorporeal membrane oxygenationUwe Zeymer, Dirk WestermannThrombosis and Haemostasis|August 14, 2018
Dual Pathway Inhibition with Low-Dose Direct Factor Xa Inhibition after Acute Coronary Syndromes-Why Is It Not Used in Clinical Practice?Uwe Zeymer, Benedikt Schrage, Dirk WestermannEuropean Heart Journal. Cardiovascular Pharmacotherapy|June 5, 2025
The role of cangrelor in acute and high-risk PCI settingsUwe Zeymer, Tobias Geisler, Dirk Westermann, et al.American Heart Journal|March 23, 2025
Hyperoxemic oxygen therapy in patients with acute anterior myocardial infarction: HOT-AAMI-design and rationale of a randomized trialUwe Zeymer, Fathema Hassinger, Peter Bramlage, et al.Cardiology and Therapy|August 20, 2014
Oral antiplatelet therapy in acute coronary syndromes: recent developmentsUwe ZeymerExpert Opinion on Pharmacotherapy|May 23, 2007
The role of eptifibatide in patients undergoing percutaneous coronary interventionUwe ZeymerInternational Journal of Cardiology|December 13, 2005
Cardiovascular benefits of acarbose in impaired glucose tolerance and type 2 diabetesUwe ZeymerHerz|April 25, 2023
The changing spectrum of cardiovascular emergencies during the COVID-19 pandemicHolger Thiele, Uwe ZeymerVascular Health and Risk Management|August 21, 2007
Management of acute coronary syndromes with fondaparinuxHarm Wienbergen, Uwe ZeymerCardiovascular Drug Reviews|December 15, 2007
A review of clinical trials with eptifibatide in cardiologyUwe Zeymer, Harm WienbergenPageof 90